000 01037 a2200289 4500
005 20250513142012.0
264 0 _c19990610
008 199906s 0 0 eng d
022 _a0964-3397
024 7 _a10.1016/s0964-3397(97)81146-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMacConnachie, A M
245 0 0 _aEcstasy poisoning.
_h[electronic resource]
260 _bIntensive & critical care nursing
_cDec 1997
300 _a365-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCritical Care
_xmethods
650 0 4 _aDantrolene
_xtherapeutic use
650 0 4 _aDesigner Drugs
_xpoisoning
650 0 4 _aHallucinogens
_xpoisoning
650 0 4 _aHumans
650 0 4 _aMuscle Relaxants, Central
_xtherapeutic use
650 0 4 _aN-Methyl-3,4-methylenedioxyamphetamine
_xpoisoning
650 0 4 _aPoisoning
_xdrug therapy
773 0 _tIntensive & critical care nursing
_gvol. 13
_gno. 6
_gp. 365-6
856 4 0 _uhttps://doi.org/10.1016/s0964-3397(97)81146-9
_zAvailable from publisher's website
999 _c9531424
_d9531424